In 2023, the share of corresponding/leading authors in scientific publications in Immunology and Microbiology in China stood at an approximate level below the forecasted figures, indicating continual growth in the subsequent years. The forecast data from 2024 to 2028 shows a progressive increase from 98.66% to 99.15%. This gradual rise suggests an entrenched trend where Chinese corresponding/leading authors maintain dominant control over scientific publications in this field.
- Year-on-year variations between 2024 and 2028 depict marginal increases around 0.12% to 0.13% per year.
- The compound annual growth rate (CAGR) over these five years reflects a mild but steady increase.
Future trends to watch for:
- The potential impact of international collaborations which could slightly alter the balance of corresponding authorship.
- Policies or incentives by Chinese institutions to further enhance domestic research leadership might amplify current trends.
